Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis.

Bernard GR
Crit Care Med. 2003 31 (1 Suppl): S85-93

PMID: 12544981 · DOI:10.1097/00003246-200301001-00012

MeSH Terms (13)

Animals Anti-Infective Agents Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Disease Models, Animal Drug Approval Humans Protein C Rats Recombinant Proteins Sepsis Severity of Illness Index Survival Rate

Connections (1)

This publication is referenced by other Labnodes entities: